Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma

被引:48
|
作者
Yu, JunJie [1 ]
Mao, WeiPu [1 ]
Sun, Si [1 ]
Hu, Qiang [1 ]
Wang, Can [1 ]
Xu, ZhiPeng [1 ]
Liu, RuiJi [1 ]
Chen, SaiSai [1 ]
Xu, Bin [2 ]
Chen, Ming [2 ,3 ]
机构
[1] Southeast Univ, Coll Med, Nanjing, Peoples R China
[2] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Lishui Peoples Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
prognostic signature; The Cancer Genome Atlas; long non-coding RNA; kidney renal clear cell carcinoma; M6A; PARTIAL NEPHRECTOMY; NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.3389/fonc.2021.663263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to construct an m6A-related long non-coding RNAs (lncRNAs) signature to accurately predict the prognosis of kidney clear cell carcinoma (KIRC) patients using data obtained from The Cancer Genome Atlas (TCGA) database. Methods The KIRC patient data were downloaded from TCGA database and m6A-related genes were obtained from published articles. Pearson correlation analysis was implemented to identify m6A-related lncRNAs. Univariate, Lasso, and multivariate Cox regression analyses were used to identifying prognostic risk-associated lncRNAs. Five lncRNAs were identified and used to construct a prognostic signature in training set. Kaplan-Meier curves and receiver operating characteristic (ROC) curves were applied to evaluate reliability and sensitivity of the signature in testing set and overall set, respectively. A prognostic nomogram was established to predict the probable 1-, 3-, and 5-year overall survival of KIRC patients quantitatively. GSEA was performed to explore the potential biological processes and cellular pathways. Besides, the lncRNA/miRNA/mRNA ceRNA network and PPI network were constructed based on weighted gene co-expression network analysis (WGCNA). Functional Enrichment Analysis was used to identify the biological functions of m6A-related lncRNAs. Results We constructed and verified an m6A-related lncRNAs prognostic signature of KIRC patients in TCGA database. We confirmed that the survival rates of KIRC patients with high-risk subgroup were significantly poorer than those with low-risk subgroup in the training set and testing set. ROC curves indicated that the prognostic signature had a reliable predictive capability in the training set (AUC = 0.802) and testing set (AUC = 0.725), respectively. Also, we established a prognostic nomogram with a high C-index and accomplished good prediction accuracy. The lncRNA/miRNA/mRNA ceRNA network and PPI network, as well as functional enrichment analysis provided us with new ways to search for potential biological functions. Conclusions We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Long Non-Coding RNA Profile Study Identifies an Immune-Related lncRNA Prognostic Signature for Kidney Renal Clear Cell Carcinoma
    Sun, Zhuolun
    Jing, Changying
    Xiao, Chutian
    Li, Tengcheng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [42] Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma
    Xu, Kangjie
    Li, Dongling
    Ji, Kangkang
    Zhang, Yanhua
    Zhang, Minglei
    Zhou, Hai
    Hou, Xuefeng
    Jiang, Jian
    Zhang, Zihang
    Dai, Hua
    Sun, Hang
    BIOLOGY DIRECT, 2024, 19 (01)
  • [43] Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
    Ju, Lincheng
    Shi, Yaxing
    Liu, Gang
    PEERJ, 2022, 10
  • [44] Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma
    Peng, Yue-Ling
    Dong, Ya-Fang
    Guo, Li-Li
    Li, Mu-Ye
    Liao, Hui
    Li, Rong-Shan
    PLOS ONE, 2023, 18 (08):
  • [45] Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
    Zhou, Chongchang
    Wang, Shumin
    Shen, Zhisen
    Shen, Yiming
    Li, Qun
    Shen, Yi
    Huang, Juntao
    Deng, Hongxia
    Ye, Dong
    Zhan, Guowen
    Li, Jinyun
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (01)
  • [46] A Novel Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Patients with Papillary Renal Cell Carcinoma
    Dang, Ruijie
    Jin, Meiling
    Nan, Jingzhu
    Jiang, Xuege
    He, Zheng
    Su, Fang
    Li, Diangeng
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 207 - 222
  • [47] Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
    Li, Zhengtian
    Du, Gang
    Zhao, Rong
    Yang, Wenkang
    Li, Chan
    Huang, Jun
    Wen, Zhenpei
    Li, Hening
    Zhang, Bo
    MEDICINE, 2021, 100 (39)
  • [48] Identification of m6A-and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
    Xie, Hongjun
    Shi, Muqi
    Liu, Yifei
    Cheng, Changhong
    Song, Lining
    Ding, Zihan
    Jin, Huanzhi
    Cui, Xiaohong
    Wang, Yan
    Yao, Dengfu
    Wang, Peng
    Yao, Min
    Zhang, Haijian
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] Identification of a Twelve Epithelial-Mesenchymal Transition-Related lncRNA Prognostic Signature in Kidney Clear Cell Carcinoma
    Xia, Qi-Dong
    Zhang, Yuan
    Li, Li-Sha
    Lu, Jun-Lin
    Xun, Yang
    Sun, Jian-Xuan
    Xu, Jin-Zhou
    Liu, Chen-Qian
    Lu, Yu-Chao
    He, Deng
    Wang, Shao-Gang
    DISEASE MARKERS, 2022, 2022
  • [50] Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma
    Chen, Mei
    Zhang, Shufang
    Nie, Zhenyu
    Wen, Xiaohong
    Gao, Yuanhui
    FRONTIERS IN ONCOLOGY, 2020, 10